Although the CLIC1 role in ccRCC has not been fully elucidated, several primary cell lines from ccRCC patients indicated that CLIC1 inhibition blocked the myosin light chain kinase (MYLK) and β3 integrin, decreasing tumor proliferation and slowing cancer progression [136]. Here, MYLK is linked to neoplasm.